CDDP-TACE | DP-TACE | ||||||||
Grade 1 | Grade 2 | Grade 3 | Grade 4 | Grade 1 | Grade 2 | Grade 3 | Grade 4 | P-value | |
Decrease in white blood cell count | 7 (18.9%) | 1 (2.7%) | 1 | 0 | 2 (4.0%) | 3 (6.0%) | 1 (2.0%) | 0 | 0.191 |
Anemia | 28 (75.7%) | 3 (8.1%) | 0 | 0 | 26 (52.0%) | 10 (20.0%) | 1 (2.0%) | 0 | 0.114 |
Decrease in platelet count | 15 (40.5%) | 14 (37.8%) | 5 (13.5%) | 0 | 22 (44.0) | 10 (20.0%) | 10 (20.0%) | 1 (2.0%) | 0.301 |
Increase in aspartate aminotransferase | 17 (45.9%) | 11 (29.7%) | 8 (21.6%) | 0 | 24 (48.0%) | 11 (22.0%) | 12 (24.0%) | 0 | 0.761 |
Increase in alanine aminotransferase | 16 (43.2%) | 6 (16.2%) | 10 (27.0%) | 0 | 31 (62.0%) | 10 (20.0%) | 0 | 0 | <0.001 |
Total bilirubin | 9 (24.3%) | 8 (21.6%) | 0 | 0 | 16 (32.0%) | 7 (14.0%) | 1 (2.0%) | 0 | 0.390 |
Fever | 24 (64.9%) | 0 | 0 | 0 | 27 (54.0%) | 0 | 0 | 0 | 0.381 |
Appetite loss | 17 (45.9%) | 0 | 0 | 0 | 19 (38.0%) | 0 | 0 | 0 | 0.513 |
Abdominal pain | 19 (51.4%) | 0 | 0 | 0 | 25 (50.0%) | 0 | 0 | 0 | 0.901 |